Pleuroparenchymal fibroelastosis as a complication of chemotherapy: A case report

Autores da FMUP
Participantes de fora da FMUP
- Vieira, ACR
- Ferra, JRM
- De Carvalho, JSV
- Melo, N
- Mota, PC
- Pereira, JM
- Moura, CS
Unidades de investigação
Abstract
Pleuroparenchymal fibroelastosis (PPFE) is a rare and recently described distinct pattern of lung apical fibrosis involving the upper lobe parenchyma and pleural dome. PPFE has definable and reproducible clinical, radiological and histopathological criteria, which allowed its classification as an independent interstitial lung disease. Several factors have been associated with PPFE, such as chemotherapy, especially with alkylating agents. The authors present a case of a 34-year-old female with previous history of Hodgkin lymphoma treated with first line chemotherapy (doxorubicin, bleomycin, vinblastine and dacarbazine). The patient had no other known comorbidities or relevant exposure to lung irritants. A total of 2 years after completing cancer treatment, the patient developed clinical and radiological features of PPFE. Given their previous history of malignancy, a biopsy of the lesion was obtained, which confirmed the diagnosis of PPFE. The authors present this case to raise awareness of this disease and to demonstrate that PPFE can develop months to years following chemotherapy treatment. Moreover, to date, none of these chemotherapy agents have been associated with the development of PPFE.
Dados da publicação
- ISSN/ISSNe:
- 2049-9450, 2049-9469
- Tipo:
- Article
- Páginas:
- -
- Link para outro recurso:
- www.scopus.com
Molecular and Clinical Oncology Spandidos Publications UK
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 2
Documentos
- Não há documentos
Filiações
Keywords
- pleuroparenchymal fibroelastosis; chemotherapy; doxorubicin; bleomycin; vinblastine; dacarbazine
Proyectos asociados
Fibrosing ILD Biomarkers That Rule Acceleration (FIBRALUNG) -NCT05635032
Investigador Principal: Hélder Novais e Bastos
Estudo Observacional Académico (FIBRALUNG) . FCT . 2021
Chronic Bronchopulmonary aspergillosis patients with underlying chronic obstructive pulmonary disease: providing grounds for biomarkers search through clinical phenotyping
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Impact of Chronic Obstructive Pulmonary Disease in surgical outcomes of lung cancer patients undergoing curative intent surgery
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Pulmonary Emphysema Regional Distribution and Extent from Chest Computed Tomography is Associated with Pulmonary Function Impairment in COPD Patients.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Non-invasive assessment of Benign Tracheal Stenosis.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Citar a publicação
Vieira A,Ferra JRM,De Carvalho JSV,Melo N,Mota PC,Bastos H,Pereira JM,Moura CS,Morais A. Pleuroparenchymal fibroelastosis as a complication of chemotherapy: A case report. Mol. Clin. Oncol. 2022. 16. (3):71.